Money will pour into I health sector. There is money sitting on the sidelines waiting. With ISN having 20 patents and a management most companies die for I think this journey has many greener pastures ahead. That said there is broad scope here for diverse respiratory orders. In other words multiple revenue streams. Expectong 4 to get bitten
- Forums
- ASX - By Stock
- ISN
- note to long term holders
note to long term holders, page-20
-
-
- There are more pages in this discussion • 65 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)